Hutchmed begins phase-three trials of lymphoma therapy in China
(Alliance News) - Hutchmed China Ltd on Monday said it had begun phase-three clinical trials of its lymphoma treatment in China. Read More
| Price | 201.00p on 24-04-2026 at 18:15:14 |
|---|---|
| Change | 0.00p 0% |
| Buy | 204.00p |
| Sell | 201.00p |
| Last Trade: | Sell 3,583.00 at 201.00p |
| Day's Volume: | 42,575 |
| Last Close: | 201.00p |
| Open: | 201.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 201.00p - 205.00p |
| 52wk Range: | 192.00p - 292.00p |
| Market Capitalisation: | £1.73b |
| VWAP: | 202.43762p |
| Shares in Issue: | 859.74m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 3,583 | 201.00p | Uncrossing Trade |
16:35:20 - 24-Apr-26 |
| Buy* | 490 | 202.997p | Ordinary |
16:16:07 - 24-Apr-26 |
| Buy* | 200 | 203.00p | Ordinary |
15:57:04 - 24-Apr-26 |
| Buy* | 10 | 202.635p | Suspected BUY Trade |
15:54:31 - 24-Apr-26 |
| Unknown* | 15,000 | 201.00p | Ordinary |
15:33:52 - 24-Apr-26 |
| Sell* | 446 | 201.00p | Automatic Execution |
15:06:44 - 24-Apr-26 |
| Buy* | 198 | 203.998p | Ordinary |
13:31:19 - 24-Apr-26 |
| Buy* | 3,000 | 203.996p | Ordinary |
13:24:32 - 24-Apr-26 |
| Buy* | 2,045 | 205.00p | Automatic Execution |
12:29:42 - 24-Apr-26 |
| Buy* | 4,642 | 204.50p | Ordinary |
12:28:48 - 24-Apr-26 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 9:30 am | RNS | 2025 Annual Report and Notice of AGM |
| 9th Apr 2026 7:00 am | RNS-R | Data to be Presented at AACR Annual Meeting 2026 |
| 23rd Mar 2026 7:00 am | RNS-R | HUTCHMED Initiates Phase III Trial of HMPL-760 |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 9th Mar 2026 9:30 am | RNS | Update on Licensed Oncology Product in China |
| 6th Mar 2026 8:30 am | RNS | Directorate change |
| 5th Mar 2026 1:00 pm | RNS-R | Publication of Form 20-F |